Charleston, SC -- (SBWIRE) -- 09/05/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Komatsu Ltd (ADR) (OTCMKTS:KMTUY), Seven Arts Entertainment Inc (OTCMKTS:SAPX), Neohydro Technologies Corp (OTCMKTS:NHYT), OncoSec Medical Inc (OTCMKTS:ONCS)
Komatsu Ltd (ADR) (OTCMKTS:KMTUY) remained a bull for the day as it reported the upward momentum of +2.22% and closed at $22.83 after gaining total volume of 42,980 shares. Its introductory price for the day was $22.62. So far, the company’s stock is down -11.60% in the three months period. In the last 6 months of trade it reported a decline of -5.88%.
Komatsu Ltd. engages in the development, manufacture, marketing, and sale of various industrial-use products and services under the Komatsu brand worldwide.
Why Should Investors Buy KMTUY After The Recent Gain? Just Go Here and Find Out
Seven Arts Entertainment Inc (OTCMKTS:SAPX) reported the gain of +25.93% and closed at $ 0.0034 with the total traded volume of 20.59 million shares. The stock's opening price was $ 0.0031. The company has a total market capitalization of $ 15.99k.
The 52-week price range of the stock remained $0.0017 - $53.00, while during last trade its minimum price was $0.003 and it gained its highest price of $0.0034. Company's last 5 days shows an uptrend with an upsurge of +47.83%. Seven Arts Entertainment, Inc. is a motion picture production and distribution company engaged in developing, financing, producing and licensing theatrical motion pictures for exhibition in domestic and foreign theatrical markets and for subsequent post-theatrical worldwide release in other forms of media, including DVD, home video, pay-per-view, and free television.
What was the Moving Force behind SAPX On Bullish Run? Read This Research Report
Neohydro Technologies Corp (OTCMKTS:NHYT) ended its day with the gaining stream with the rise of +12.24% and closed at the price of $0.0550 after opening at $0.05. Stock traded during its last trading session with the total volume of 1.64 million shares, as compared to its average volume of 1.33 million shares.
During the previous session, the company’s minimum price was $0.05, while it touched its highest price for the day at $0.06. NHYT’s beta value stands at -4.20 points. Neohydro Technologies Corp. does not have significant operations. The company intends to seek a company or companies that it can acquire or merge with. Previously, it was engaged in the business of installing patented turbo systems that were proven to assist an engine in its operation in the light and heavy-duty trucking industry.
For How Long NHYT will Fight for Profitability? Read This Trend Analysis report
OncoSec Medical Inc (OTCMKTS:ONCS) reported the gain of +4.31%, to close at $0.303, with the overall traded volume of 618,365 shares.
So far, in the past three months, the stock is up +5.40%. The 52-week range for the stock is $0.18 and $0.49 and during the previous trading session the stock touched its highest price at $0.31. Its introductory price for the day was $0.29. OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.
Will ONCS Continue To Move Higher? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)